Worries that surgery patients would have a tougher recovery if their doctors had to abide by a five-day limit on opioid pain medication prescriptions didn’t play out as expected, a new study finds.
Q&A with David Hutton
David Hutton, a professor of Health Management and Policy and Global Public Health, discusses the cost-effectiveness of RSV vaccination in older adults. Hutton and a group of University of Michigan researchers recently presented research on the topic during a meeting for the CDC's Advisory Committee on Immunization Practices (ACIP).
Q&A with Peter Song
Biostatistics expert Peter Song and team have created a tool to assess the effectiveness of preventive measures in the fight against the COVID-19, still a new disease with many unknowns. The model lets us compare the impact of different levels of intervention so different locales can develop better strategies and policies to flatten the coronavirus curve.
New Research from Tarlise Townsend and Freida Blostein
Broad distribution of the opioid reversal drug naloxone is highly cost-effective in reducing fatal overdoses, according to a new University of Michigan study.
New Contribution from Rebecca Haffajee
As the U.S. opioid crisis gained steam a decade ago, Michigan was flooded by pain pills by suppliers and distributors who seemed more focused on sales than the drugs’ dangers, according to recently released documents.
Rebecca Haffajee Quoted by ABC News
U.S. overdose deaths last year likely fell for the first time in nearly three decades, preliminary numbers suggest.